These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome]. Hidasi E; Soltész P Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome in the emergency department. McGillicuddy DC; Walker O; Shapiro NI; Edlow JA Ann Emerg Med; 2006 Apr; 47(4):390-3. PubMed ID: 16546626 [No Abstract] [Full Text] [Related]
7. [Treatment of Guillain-Barré Syndrome]. Nomura K Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955 [TBL] [Abstract][Full Text] [Related]
8. Guillain-barré syndrome in pregnancy: early diagnosis and treatment is essential for a favorable outcome. Campos da Silva F; de Moraes Paula G; Dos Santos Esteves Automari CV; Mendes de Almeida DS; Ubirajara Cavalcanti Guimarães R Gynecol Obstet Invest; 2009; 67(4):236-7. PubMed ID: 19293590 [TBL] [Abstract][Full Text] [Related]
10. [Acute and chronic inflammatory neuropathies--therapy]. Köller H; Kieseier BC; Jander S; Hartung HP Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1405-7. PubMed ID: 12813675 [No Abstract] [Full Text] [Related]
11. [Guillain-Barré syndrome: epidemiological, clinical and therapeutic insight]. Raphaël JC; Sharshar T Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S35-40. PubMed ID: 10896987 [TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome in elderly people. Leung SS J Am Geriatr Soc; 2008 Feb; 56(2):381-2. PubMed ID: 18251836 [No Abstract] [Full Text] [Related]
13. Blindness, weakness, and tingling. Biotti D; Vignal C; Sharshar T; Gout O; McCoy AN; Miller NR Surv Ophthalmol; 2012 Nov; 57(6):565-72. PubMed ID: 22398335 [TBL] [Abstract][Full Text] [Related]
14. Steroids in the Guillain-Barré syndrome: is there a therapeutic window? Van Koningsveld R; Van Doorn PA Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470 [No Abstract] [Full Text] [Related]
15. Management of children with Guillain-Barré syndrome. Agrawal S; Peake D; Whitehouse WP Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):161-8. PubMed ID: 18032711 [No Abstract] [Full Text] [Related]
16. Guillain-Barré syndrome. Office of Communications and Public Liaison, National Institute of Neurological Disorders and Stroke, National Institutes of Health Can J Neurosci Nurs; 2008; 30(2):20. PubMed ID: 18649780 [No Abstract] [Full Text] [Related]
17. [Immunoglobulins and corticoids in Guillain-Barre syndrome: a report of a new case. Letter]. Riol Diego M; Jiménez Monteagudo M; López de Mesa R; Alzina de Aguilar V An Esp Pediatr; 1996 Nov; 45(5):547-9. PubMed ID: 9036793 [No Abstract] [Full Text] [Related]
18. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis. Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414 [TBL] [Abstract][Full Text] [Related]
19. Guillain-Barre syndrome: a clinical study in King Chulalongkorn Memorial Hospital. Areeyapinan P; Phanthumchinda K J Med Assoc Thai; 2010 Oct; 93(10):1150-5. PubMed ID: 20973317 [TBL] [Abstract][Full Text] [Related]
20. A woman with rapidly progressive weakness and sensory loss. Attreed NJ; Shields SA BMJ; 2011 Dec; 343():d7845. PubMed ID: 22188943 [No Abstract] [Full Text] [Related] [Next] [New Search]